Adjudicating Neurocognitive Endophenotypes for Schizophrenia
Overview
Authors
Affiliations
Although genetic influences on schizophrenia are well established, localization of the genes responsible for this illness has proven extremely difficult. Given evidence that genes predisposing to schizophrenia may be transmitted without expression of the clinical phenotype, efforts have focused on developing endophenotypes. While several neuropsychological measures have been proposed to be endophenotypes, few studies have systematically assessed batteries of neurocognitive tests to determine which tests are most sensitive to liability for the illness. Two hundred sixty-nine Latino individuals were administered a standard neuropsychological battery. Two hundred fourteen of these were members of families with at least two siblings diagnosed with schizophrenia or schizoaffective disorder. The remaining were community controls without history of major psychiatric illness. Neurocognitive measures found to be heritable were entered into analyses designed to determine which tests covary with the degree of genetic relationship to affected individuals. Although five measures were found to uniquely model genetic liability for schizophrenia, digit symbol coding was the most sensitive. To assess the specificity of these endophenotypes, performance on these measures were compared to family members with bipolar and unipolar affective disorders. These markers clearly distinguished between individuals with psychotic illnesses and those with major depression. As measures contributed uniquely to discriminate individuals at varying risk for schizophrenia, our findings imply multiple independently inherited elements to the liability for the illness. We present a practical model for adjudicating endophenotypes and determining which measures are best suited for use in linkage analyses.
A comparative study of cognitive functions between schizophrenia and obsessive-compulsive disorder.
Zou J, Yuan B, Hu M, Yuan X, Tang J, Chen J Heliyon. 2023; 9(3):e14330.
PMID: 36938396 PMC: 10015237. DOI: 10.1016/j.heliyon.2023.e14330.
The contribution of copy number variants to psychiatric symptoms and cognitive ability.
Mollon J, Almasy L, Jacquemont S, Glahn D Mol Psychiatry. 2023; 28(4):1480-1493.
PMID: 36737482 PMC: 10213133. DOI: 10.1038/s41380-023-01978-4.
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups.
Saether L, Ueland T, Haatveit B, Maglanoc L, Szabo A, Djurovic S Mol Psychiatry. 2022; 28(3):1284-1292.
PMID: 36577840 PMC: 10005942. DOI: 10.1038/s41380-022-01924-w.
Deng M, Liu Z, Zhang W, Wu Z, Cao H, Yang J Schizophrenia (Heidelb). 2022; 8(1):54.
PMID: 35853905 PMC: 9261080. DOI: 10.1038/s41537-022-00260-w.
Klauser P, Cropley V, Baumann P, Lv J, Steullet P, Dwir D Schizophr Bull Open. 2021; 2(1):sgab033.
PMID: 34901867 PMC: 8650074. DOI: 10.1093/schizbullopen/sgab033.